Mind Medicine MindMed(MNMD.US)

Last Updated 19:00:00 ET
longbridge loading

FDA Moves To Fast-Track Psychedelic Therapies For Mental Health

rttnews·
US
ATAI
+0.86%
US
CYBN
0.00%
US
MNMD
0.00%
rttnews·
US
ATAI
+0.86%
US
CYBN
0.00%
US
MNMD
0.00%

Trump Order To Accelerate Treatments For Serious Mental Illness

rttnews·
US
CMPS
+4.42%
US
MNMD
0.00%
US
PSIL
+0.95%
rttnews·
US
CMPS
+4.42%
US
MNMD
0.00%
US
PSIL
+0.95%

Trump: Accelerate access to research on psychedelic drugs

Wallstreetcn·
US
GHRS
-2.91%
US
MNMD
0.00%
US
ATAI
+0.86%
Wallstreetcn·
US
GHRS
-2.91%
US
MNMD
0.00%
US
ATAI
+0.86%

Women's health startup Midi Health hit a $1 billion valuation. Its founder says AI changed everything.

businessinsider·
US
MNMD
0.00%
US
FBT
-0.22%
US
IBB
-0.52%
businessinsider·
US
MNMD
0.00%
US
FBT
-0.22%
US
IBB
-0.52%

11:03 ETSonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems

prnewswire·
US
SOND
0.00%
US
BBH
-0.44%
US
LABU
-2.67%
prnewswire·
US
SOND
0.00%
US
BBH
-0.44%
US
LABU
-2.67%

NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease

The newswire.ca·
US
PBE
-0.19%
US
XBI
-0.80%
US
CMND
-6.35%
The newswire.ca·
US
PBE
-0.19%
US
XBI
-0.80%
US
CMND
-6.35%

MedWellAI, Inc. SEC 10-Q Report

TradingView·
US
IHE
-0.01%
US
IBBQ
-0.21%
US
FBT
-0.22%
TradingView·
US
IHE
-0.01%
US
IBBQ
-0.21%
US
FBT
-0.22%

Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile of CMND-100 in Ongoing Phase I/IIa Clinical Trial | CMND Stock News

StockTitan·
US
PBE
-0.19%
US
IXJ
-0.18%
US
PRME
-2.65%
StockTitan·
US
PBE
-0.19%
US
IXJ
-0.18%
US
PRME
-2.65%

Clearmind Medicine partners to develop intranasal MEAI for addiction & CNS disorders, boosting bioavailability & clinical progress.

Unusual Whales·
US
IXJ
-0.18%
US
XBI
-0.80%
US
BBH
-0.44%
Unusual Whales·
US
IXJ
-0.18%
US
XBI
-0.80%
US
BBH
-0.44%
© 2026 Longbridge｜Disclaimer